Csl
Trump serves Australia $3bn dose of bad medicine
Property stocks feel RBA hold pain; Lifestyle Communities smashed
ASX lifts on rate cut hopes
Tax ‘Trojan horse’ realises business chiefs’ worst fears
How CSL expects its lifesaving products to evade tariffs
Vaccine and blood products maker CSL at risk of tariff contagion
Trump dump: ASX 200, Asian equities down as US tariffs roll in
Pharma firms avoid train wreck, so far
US vaccine aversion a headwind for CSL
ASX ends flat with CSL the main drag
ASX 200 trims falls; ACCC gives nod for Virgin-Qatar deal
ASX 200 hits new records as CSL, CBA gain; Star cops first strike
Santos serious about reducing emissions, court hears
CSL defends executive pay after protest vote
‘Mixed bag’: ASX trades sideways
European car industry in uncharted territory
ASX flat after choppy session ahead of US Fed rate call
CSL using AI to tackle serious diseases
Small farmers take on the ‘carbon cowboys’
Telstra back in the winners’ circle but A-REITs go missing
CSL shares dip on weaker than expected guidance
Healthcare stocks dragged down by CSL
Why CSL doesn’t see itself as another big pharma
ASX ticks up; CSL’s worst day this year; wages growth cools
Healthy prospects for savvy investors
Greens’ anti-gas plan would sabotage energy security
Clear economic danger of ideological frolics and wishful thinking.
Moving up the carbon capture value chain
ASX 200 ends up 1pc; Guzman IPO
What to do when your business flight is cancelled
Original URL: https://www.theaustralian.com.au/topics/csl/page/2